𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pinhole imaging of131I-metaiodobenzylguanidine (131I-MIBG) in an animal model of neuroblastoma

✍ Scribed by Roberto Accorsi; MichaelJ. Morowitz; Martin Charron; JohnM. Maris


Publisher
Springer-Verlag
Year
2003
Tongue
English
Weight
656 KB
Volume
33
Category
Article
ISSN
0301-0449

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


131I-metaiodobenzylguanidine treatment i
✍ Cottino, F. ;Mussa, G. C. ;Madon, E. ;Favero, A. ;Silvestro, L. ;Grazia, G. πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 265 KB

Poor results with 131I-meta-iodobenzylguanidine (MIBG) therapy have been obtained in two children with stage IV neuroblastoma treated after partial surgery and unsatisfactory combination chemotherapy. Both patients' response to treatment (four and three 1-month-spaced courses, respectively; cumulati

Therapeutic use of131I-metaiodobenzylgua
✍ Hartmann, O. ;Lumbroso, J. ;Lemerle, J. ;Schlumberger, M. ;Ricard, M. ;Aubert, B πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 576 KB

Effects of high activities of I 131 meta-iodobenzylguanidine (mIBG) were evaluated in nine children with advanced neuroblastoma. All patients had been previously heavily treated and had either primarily refractory disease or resistant relapse. Twenty-two doses of mIBG labeled with 1.3 to 4 GBq (35-1

Position paper: Role of131I-metaiodobenz
✍ Mastrangelo, Renato; Tornesello, Assunta; Mastrangelo, Stefano πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 67 KB πŸ‘ 1 views

Background. Standard chemo-radiotherapy methods for the treatment of children with advanced neuroblastoma (NBL) including bone marrow transplant approaches have been disappointing. These poor results can be ascribed to the evolution of residual drug-resistant cell populations. Curative attempts shou

Treatment of neuroblastoma with131I-meta
✍ Bestagno, M. ;Guerra, P. ;Puricelli, G. P. ;Colombo, L. ;Calculli, G. πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 182 KB

Eight patients affected by neuroblastoma were treated with 18 courses of 131I-meta-iodobenzylguanidine (MIBG). They all had been judged as "nonresponders" to conventional treatments. Six had stage IV disease: of these, five, with massive marrow involvement, had poor results, mainly because of marrow